<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2018-14-6-846-851</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-1797</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2</article-title><trans-title-group xml:lang="ru"><trans-title>Эффективность хронофармакотерапии в зависимости от солечувствительности у пациентов с артериальной гипертонией и сахарным диабетом 2 типа</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скибицкий</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skibitskiy</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, зав. кафедрой госпитальной терапии</p></bio><bio xml:lang="en"><p>MD, PhD, Professor, Head of Chair of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселев</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiselev</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент, кафедра госпитальной терапии</p></bio><bio xml:lang="en"><p>MD, Assistant, Chair of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фендрикова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fendrikova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент, кафедра госпитальной терапии</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor, Chair of Hospital Therapy</p></bio><email xlink:type="simple">alexandra2310@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кубанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>04</day><month>01</month><year>2019</year></pub-date><volume>14</volume><issue>6</issue><fpage>846</fpage><lpage>851</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Skibitskiy V.V., Kiselev A.A., Fendrikova A.V., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Скибицкий В.В., Киселев А.А., Фендрикова А.В.</copyright-holder><copyright-holder xml:lang="en">Skibitskiy V.V., Kiselev A.A., Fendrikova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/1797">https://www.rpcardio.online/jour/article/view/1797</self-uri><abstract><p>Aim. To study the effect of two regimens of combined antihypertensive therapy during the day on daily monitoring of arterial pressure, central aortic pressure, and arterial stiffness, depending on the salt sensitivity of hypertensive patients with diabetes mellitus type 2. Material and methods. 130 hypertensive patients with type 2 diabetes mellitus were included into the study. They were divided into 2 subgroups: salt-sensitive (group 1) and salt-resistant (group 2), and then randomized to subgroups A and B of ongoing therapy: in the morning ramipril and indapamide retard, bedtime – amlodipine (subgroup 1A and 2A); or in the morning amlodipine and indapamide retard, bedtime – ramipril (subgroup 1B and 2B). Initially and after 24 weeks of antihypertensive therapy, 24-hour blood pressure monitoring was performed, the indices of central aortic pressure and arterial stiffness were determined. Results. After 24 weeks, in all subgroups, there was a significant positive dynamics of the parameters of 24-hour blood pressure monitoring, central aortic pressure and arterial stiffness indices. In the subgroup 1В, it was registered a significant improvement in the majority of parameters of 24-hour blood pressure monitoring (decrease in 24-hours systolic BP by 24.4%, 24-hours diastolic BP by 22.1%; p&lt;0.05), central aortic pressure (decrease in aortal systolic BP by 15.9%, aortal diastolic BP by 20.8%; p&lt;0.05) and vascular wall stiffness parameters (decrease in pulse wave velocity by 13.8%; p&lt;0.05) in comparison with group 1A (decrease in 24-hours systolic BP by 17.5%, 24-hours diastolic BP by 14.6%, aortal systolic BP by 12.7%, aortal diastolic BP by 9.7%, pulse wave velocity by 9.2%; p&lt;0.05 in comparison with the group 1B). In the case of salt-resistant patients, there were comparable positive changes in the parameters of 24-hour blood pressure monitoring, central aortic pressure and arterial stiffness indices against the background of both dosing regimens during the day. Conclusion. In the study, it was demonstrated the more pronounced antihypertensive and vasoprotective efficacy of the combination of thiazide-like diuretic with calcium channel blocker in the morning and ACE inhibitor in bedtime compared to the alternative regimen of prescribed pharmacotherapy in salt-sensitive patients, and comparable efficacy of both regimens in salt-resistant hypertensive patients with diabetes mellitus type 2.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Изучить влияние двух режимов приема в течение суток комбинированной антигипертензивной терапии на показатели суточного мониторирования артериального давления (АД), центрального аортального давления и жесткости сосудистой стенки у солечувствительных и солерезистентных больных артериальной гипертонией (АГ) с сахарным диабетом (СД) 2 типа. Материал и методы. Включено 130 пациентов с АГ и СД 2 типа, которые были разделены на 2 группы: солечувствительные (группа 1) и солерезистентные (группа 2), а затем – на подгруппы А и Б: утром – тиазидоподобный диуретик и ингибитор ангиотензинпревращающего фермента (иАПФ), вечером – антагонист кальция (АК) (подгруппы 1А и 2А); или утром – тиазидоподобный диуретик и АК, а вечером – иАПФ (подгруппы 1Б и 2Б). Исходно и через 24 нед терапии проводилось суточное мониторирование артериального давления (СМАД), определялись показатели центрального аортального давления (ЦАД) и жесткости сосудистой стенки. Результаты. Через 24 нед во всех подгруппах наблюдалась значимая положительная динамика параметров СМАД, ЦАД и показателей артериальной жесткости. В подгруппе 1Б регистрировалось статистически более значимое улучшение большинства параметров СМАД (снижение систолического АД (САДсутки) на 24,4%, диастолического АД (ДАДсутки) на 22,1%; p&lt;0,05), ЦАД (снижение САДaoрта на 15,9%, ДАДaoрта на 20,8%; p&lt;0,05) и показателей жесткости сосудистой стенки (снижение скорости распространения пульсовой волны на 13,8%; p&lt;0,05) по сравнению с подгруппой 1А (снижение САДсутки на 17,5%, ДАДсутки на 14,6%; снижение САДaoрта на 12,7%, ДАДaoрта на 9,7%; снижение скорости распространения пульсовой волны на 9,2%; p&lt;0,05 по сравнению с погруппой 1Б). У солерезистентных пациентов отмечались сопоставимые позитивные изменения параметров СМАД, ЦАД и параметров артериальной жесткости на фоне обоих режимов дозирования препаратов в течение суток. Заключение. Показана более выраженная антигипертензивная и вазопротективная эффективность комбинации тиазидоподобного диуретика с АК утром и иАПФ вечером по сравнению с альтернативным режимом назначения фармакотерапии у солечувствительных пациентов, и сопоставимая эффективность обоих режимов у солерезистентных больных АГ с СД 2 типа.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронофармакотерапия</kwd><kwd>центральное аортальное давление</kwd><kwd>жесткость сосудистой стенки</kwd><kwd>солечувствительность</kwd><kwd>артериальная гипертония</kwd><kwd>сахарный диабет 2 типа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chrono-pharmacotherapy</kwd><kwd>central aortic pressure</kwd><kwd>arterial stiffness</kwd><kwd>salt sensitivity</kwd><kwd>hypertension</kwd><kwd>type 2 diabetes mellitus</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность ФР сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014;10:4-12</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., ZhernakovaYu.V., Oshchepkova E.V. et al. Prevalence of Cardiovascular Risk Factors in Russian Population of Patients With Arterial Hypertension. Kardiologia. 2014;10:4-12. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rydén L., Grant P.J., Anker S.D. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-87. doi:10.1093/eurheartj/eht108.</mixed-citation><mixed-citation xml:lang="en">Rydén L., Grant P.J., Anker S.D. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-87. doi:10.1093/eurheartj/eht108.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">London G.M., Asmar R.G., O’Rourke M.F., Safar M.E. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99. doi:10.1016/j.jacc.2003.07.039.</mixed-citation><mixed-citation xml:lang="en">London G.M., Asmar R.G., O’Rourke M.F., Safar M.E. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99. doi:10.1016/j.jacc.2003.07.039.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B., Lacy P.S., Thom S.M. et al. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25. doi:10.1161/CIRCULATIONAHA.105.595496.</mixed-citation><mixed-citation xml:lang="en">Williams B., Lacy P.S., Thom S.M. et al. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25. doi:10.1161/CIRCULATIONAHA.105.595496.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Qi H., Liu Z., Cao H. et al. Comparative Efficacy of Antihypertensive Agents in Salt-Sensitive Hypertensive Patients: A Network Meta-Analysis. Am J Hypertens. 2018;31(7):835-46. doi:10.1093/ ajh/hpy027.</mixed-citation><mixed-citation xml:lang="en">Qi H., Liu Z., Cao H. et al. Comparative Efficacy of Antihypertensive Agents in Salt-Sensitive Hypertensive Patients: A Network Meta-Analysis. Am J Hypertens. 2018;31(7):835-46. doi:10.1093/ ajh/hpy027.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Isobe-Sasaki Y., Fukuda M., Ogiyama Y. et al. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy. Physiological Reports. 2017;5(11):e13309. doi:10.14814/phy2.13309.</mixed-citation><mixed-citation xml:lang="en">Isobe-Sasaki Y., Fukuda M., Ogiyama Y. et al. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy. Physiological Reports. 2017;5(11):e13309. doi:10.14814/phy2.13309.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Харченко В.И., Люсов В.А., Рифаи М.А. и др. Солевые, водные нагрузки и водно-натриевый обмен у больных гипертонической болезнью. Терапевтический Архив. 1984;56(12):48-55</mixed-citation><mixed-citation xml:lang="en">Kharchenko V.I., Luce V.A., Rifai M.A. et al. Salt, water stress and water-sodium metabolism in patients with essential hypertension. Terapevticheskii Arkhiv. 1984;56(12):48-55. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. doi:10.1097/HJH.0b013e328364ca4c.</mixed-citation><mixed-citation xml:lang="en">ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. doi:10.1097/HJH.0b013e328364ca4c.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Васюк Ю.А., Иванова С.В., Школьник Е.Л. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная Терапия и Профилактика. 2016;15(2):4-19</mixed-citation><mixed-citation xml:lang="en">Vasyuk Y.A., Ivanova S.V., Shkolnik E.L. et al. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016;15(2):4-19. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ohashi N., Isobe S., Ishigaki S., Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 2017;40(5):413-422. doi:10.1038/hr.2016.166.</mixed-citation><mixed-citation xml:lang="en">Ohashi N., Isobe S., Ishigaki S., Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 2017;40(5):413-422. doi:10.1038/hr.2016.166.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Combe R., Mudgett J., El Fertak L. et al. How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains. PLoS One. 2016;11(4):e0153472. doi:10.1371/journal.pone.0153472</mixed-citation><mixed-citation xml:lang="en">Combe R., Mudgett J., El Fertak L. et al. How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains. PLoS One. 2016;11(4):e0153472. doi:10.1371/journal.pone.0153472</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Harvey A., Montezano A.C., Lopes R.A. et al. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol 2016; 32:659-68. doi:10.1016/ j.cjca.2016.02.070.</mixed-citation><mixed-citation xml:lang="en">Harvey A., Montezano A.C., Lopes R.A. et al. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol 2016; 32:659-68. doi:10.1016/ j.cjca.2016.02.070.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Котовская Ю.В., Кобалава Ж.Д. Аортальное давление: современные представления о клиническом и прогностическом значении его показателей. Медицинский Совет. 2013;4:26-33</mixed-citation><mixed-citation xml:lang="en">Kotovskaya Yu.V., Kobalava Zh.D. Aortic pressure: modern views on the clinical and prognostic value of its indicators. Meditsinskii Sovet. 2013;4:26-33. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
